Cargando…
Estimating dose-response for time to remission with instrumental variable adjustment: the obscuring effects of drug titration in Genome Based Therapeutic Drugs for Depression Trial (GENDEP): clinical trial data
BACKGROUND: Threshold regression, in which time to remission is modelled as a stochastic drift towards a boundary, is an alternative to the proportional hazards survival model and has a clear conceptual mechanism for examining the effects of drug dose. However, for both threshold regression and prop...
Autores principales: | Hellier, Jennifer, Emsley, Richard, Pickles, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942263/ https://www.ncbi.nlm.nih.gov/pubmed/31900198 http://dx.doi.org/10.1186/s13063-019-3810-9 |
Ejemplares similares
-
Suicidal ideation during treatment of depression with escitalopram and nortriptyline in Genome-Based Therapeutic Drugs for Depression (GENDEP): a clinical trial
por: Perroud, Nader, et al.
Publicado: (2009) -
Clinical lessons from GENDEP for the treatment of depression
por: Aitchison, Katherine J
Publicado: (2010) -
Genes associated with anhedonia: a new analysis in a large clinical trial (GENDEP)
por: Ren, Hongyan, et al.
Publicado: (2018) -
Improved adherence adjustment in the Coronary Drug Project
por: Murray, Eleanor J., et al.
Publicado: (2018) -
Methods in the design and implementation of the Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE) clinical trial
por: Curley, Martha A. Q., et al.
Publicado: (2018)